Dongdong Wang
Bengbu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Multiomics and Genomic Alteration Characterization Identifies VDAC1 as a Mitochondrial-Associated Biomarker in Pancreatic Cancer.
Journal: Human mutation
Published: February 06, 2026
H2AFY regulates autophagy-dependent ferroptosis through ITM2A in hepatocellular carcinoma progression.
Journal: Archives of biochemistry and biophysics
Published: December 25, 2025
Machine learning-driven prediction of immune checkpoint inhibitor responses against cholangiocarcinoma: a bile biopsy perspective.
Journal: Frontiers in immunology
Published: April 19, 2025
Integrative analysis of bulk and single-cell transcriptomic data reveals novel insights into lipid metabolism and prognostic factors in hepatocellular carcinoma.
Journal: Discover oncology
Published: June 21, 2024
The COL7A1/PI3K/AKT axis regulates the progression of cholangiocarcinoma.
Journal: Heliyon
Published: April 09, 2024
The formation of unsaturated IrOx in SrIrO3 by cobalt-doping for acidic oxygen evolution reaction.
Journal: Nature communications
Published: November 09, 2023
MiR-186-5p prevents hepatocellular carcinoma progression by targeting methyltransferase-like 3 that regulates m6A-mediated stabilization of follistatin-like 5.
Journal: Heliyon
Published: June 28, 2023
HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis.
Journal: World journal of surgical oncology
Published: May 16, 2023
Bile metabolites as diagnostic biomarkers for perihilar cholangiocarcinoma.
Journal: Scientific reports
Published: September 14, 2022
Application of mesohepatectomy with caudate lobectomy for the treatment of type III-IV hilar cholangiocarcinoma: a single-center retrospective study.
Journal: European journal of medical research
Published: August 20, 2022
Last Updated: 09/26/2026